Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion

Molecular Endocrinology

Volumn 20, Issue 7, 2006, Pages 1644-1651

  Tsukiyama, Katsushi ^a,e   Yamada, Yuichiro ^a   Yamada, Chizumi ^a   Harada, Norio ^a   Kawasaki, Yukiko ^a   Ogura, Masahito ^a   Bessho, Kazuhisa ^a   Li, Minqi ^b   Amizuka, Norio ^b   Sato, Masahiro ^c   Udagawa, Nobuyuki ^c   Takahashi, Naoyuki ^c   Tanaka, Kiyoshi ^d   Oiso, Yutaka ^e   Seino, Yutaka ^a,f  

^a KYOTO UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c MATSUMOTO DENTAL UNIVERSITY   (Japan)

^d KYOTO WOMEN'S UNIVERSITY   (Japan)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f KANSAI ELECTRIC POWER CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GASTRIC INHIBITORY POLYPEPTIDE; GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR; GASTROINTESTINAL HORMONE; HORMONE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CALCIUM INTAKE; CELL COUNT; CONTROLLED STUDY; DUODENUM; ENCHONDRAL OSSIFICATION; ENDOCRINE SYSTEM; FOOD INTAKE; HORMONE RELEASE; IN VITRO STUDY; KILLER CELL; MALE; MORPHOMETRICS; MOUSE; MULTINUCLEAR CELL; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRABECULAR BONE; WILD TYPE;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BONE RESORPTION; CALCIUM; EATING; GASTRIC INHIBITORY POLYPEPTIDE; MALE; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; OSTEOPOROSIS; SIGNAL TRANSDUCTION; TIBIA;

EID: 33745658853     PISSN: 08888809     EISSN: 08888809     Source Type: Journal    
DOI: 10.1210/me.2005-0187     Document Type: Article

References (31)

1. Cooper C, Melton LJI 1996 Magnitude and impact of osteoporosis and fractures. In: Kelsey J, ed. Osteoporosis. San Diego: Academic Press; 419-434
2. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ 1999 Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20:345-357
3. Ducy P, Schinke T, Karsenty G 2000 The osteoblast: a sophisticated fibroblast under central surveillance. Science 289:1501-1504
4. Teitelbaum SL, Ross FP 2003 Genetic regulation of osteoclast development and function. Nat Rev Genet 4:638-649
5. Lips P 2001 Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477-501
6. Dawson-Hughes B, Dallal GE, Krall EA, Sadowski L, Sahyoun N, Tannenbaum S 1990 A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 323:878-883
7. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE 1997 Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337:670-676
8. Bonjour JP, Carrie AL, Ferrari S, Clavien H, Slosman D, Theintz G, Rizzoli R 1997 Calcium-enriched foods and bone mass growth in prepubertal girls: a randomized, double-blind, placebo-controlled trial. J Clin Invest 99:1287-1294
9. Pederson RA 1994 Biochemistry and physiology. In: Walsh JH, Dockray GJ, eds. Gut peptides. New York: Raven; 217-260
10. Vilsboll T, Krarup T, Sonne J, Madsbad S, Volund A, Juul AG, Holst JJ 2003 Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab 88:2706-2713
11. Brown JC, Dryburgh JR 1971 A gastric inhibitory polypeptide. II. The complete amino acid sequence. Can J Biochem 49:867-872
12. Pederson RA, Schubert HE, Brown JC 1975 The insulinotropic action of gastric inhibitory polypeptide. Can J Physiol Pharmacol 53:217-223
13. Takeda J, Seino Y, Tanaka K, Fukumoto H, Kayano T, Takahashi H, Mitani T, Kurono M, Suzuki T, Tobe T, Imura H 1987 Sequence of an intestinal cDNA encoding human gastric inhibitory polypeptide precursor. Proc Natl Acad Sci USA 84:7005-7008
14. Inagaki N, Seino Y, Takeda J, Yano H, Yamada Y, Bell GI, Eddy RL, Fukushima Y, Byers MG, Shows TB, Imura H 1989 Gastric inhibitory polypeptide: structure and chromosomal localization of the human gene. Mol Endocrinol 3:1014-1021
15. Yamada Y, Hayami T, Nakamura K, Kaisaki PJ, Someya Y, Wang CZ, Seino S, Seino Y 1995 Human gastric inhibitory polypeptide receptor: cloning of the gene (GIPR) and cDNA. Genomics 29:773-776
16. Bollag RJ, Zhong Q, Ding KH, Phillips P, Zhong L, Qin F, Cranford J, Mulloy AL, Cameron R, Isales CM 2001 Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects. Mol Cell Endocrinol 177:35-41
17. Miyawaki K, Yamada Y, Yano H, Niwa H, Ban N, Ihara Y, Kubota A, Fujimoto S, Kajikawa M, Kuroe A, Tsuda K, Hashimoto H, Yamashita T, Jomori T, Tashiro F, Miyazaki J, Seino Y 1999 Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci USA 96:14843-14847
18. Tsukiyama K, Yamada Y, Miyawaki K, Hamasaki A, Nagashima K, Hosokawa M, Fujimoto S, Takahashi A, Toyoda K, Toyokuni S, Oiso Y, Seino Y 2004 Gastric inhibitory polypeptide is the major insulinotropic factor in KATP null mice. Eur J Endocrinol 151:407-412
19. Miyawaki K, Yamada Y, Ban N, Ihara Y, Tsukiyama K, Zhou H, Fujimoto S, Oku A, Tsuda K, Toyokuni S, Hiai H, Mizunoya W, Fushiki T, Holst JJ, Makino M, Tashita A, Kobara Y, Tsubamoto Y, Jinnouchi T, Jomori T, Seino Y 2002 Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 8:738-742
20. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434-1441
21. Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM 2003 The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 349:1216-1226
22. Jilka RL, Weinstein RS, Bellido T, Parfitt AM, Manolagas SC 1998 Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res 13:793-802
23. Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC 1999 Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 104:439-446
24. Bellido T, Ali AA, Plotkin LI, Fu Q, Gubrij I, Roberson PK, Weinstein RS, O'Brien CA, Manolagas SC, Jilka RL 2003 Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism. J Biol Chem 278:50259-50272
25. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610
26. Amizuka N, Kwan MY, Goltzman D, Ozawa H, White JH 1999 Vitamin D3 differentially regulates parathyroid hormone/parathyroid hormone-related peptide receptor expression in bone and cartilage. J Clin Invest 103:373-381
27. Nishino I, Amizuka N, Ozawa H 2001 Histochemical examination of osteoblastic activity in op/op mice with or without injection of recombinant M-CSF. J Bone Miner Metab 19:267-276
28. Suda T, Jimi E, Nakamura I, Takahashi N 1997 Role of 1α,25- dihydroxyvitamin D3 in osteoclast differentiation and function. Methods Enzymol 282:223-235
29. Li X, Udagawa N, Itoh K, Suda K, Murase Y, Nishihara T, Suda T, Takahashi N 2002 p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology 143:3105-3113
30. Udagawa N, Takahashi N, Yasuda H, Mizuno A, Itoh K, Ueno Y, Shinki T, Gillespie MT, Martin TJ, Higashio K, Suda T 2000 Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology 141:3478-3484
31. 2+ influx by glibenclamide induces apoptosis in RINm5F cells. Biochem Biophys Res Commun 271:422-428